Home LiteratureArticle Details
PMID: 8895148 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus.

The Journal of rheumatology ·Vol. 23 ·No. 10 ·1996-10-00 ·Pages 1725-8

Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P

Abstract

To assess the role of polymorphisms in the promoter region of the tumor necrosis factor-alpha (TNF-alpha) gene in susceptibility to systemic lupus erythematosus (SLE). Two ethnically different populations of patients with SLE (49 white from the UK and 49 black from South Africa) were genotyped for TNF-238 and TNF-308 polymorphisms using amplification refractory mutation system-polymerase chain reaction (PCR). HLA-DR genotypes were assigned to the patients and controls either serologically or by PCR and sequence specific oligonucleotides. The frequencies of the respective variants were compared between patients and ethnically matched controls. No significant differences were found in the frequency of the TNF-238 variants in either ethnic group. At TNF-308, the TNF2 variant was significantly increased (p = 0.04) in white patients with SLE compared to controls. However, TNF2 was strongly associated with HLA-DR3 (p = 0.00002), which also showed a strong trend of increase in the white patients (p = 0.06). In contrast, in the black patients with SLE in whom DR2 but not DR3 was increased, the frequency of TNF2 was actually reduced rather than increased. The increase of TNF2 in Caucasians with SLE is most likely due to linkage disequilibrium between TNF2 and DR3. Furthermore, the observation that TNF2 seems to be reduced in blacks with SLE strongly suggests this polymorphism is not an independent risk factor for SLE. Overall, our data indicate that the TNF-238 and TNF-308 promoter polymorphisms do not confer susceptibility to SLE.

MeSH Terms
Base Sequence Blacks/genetics Gene Frequency/genetics HLA-DR Antigens/genetics Humans Lupus Erythematosus, Systemic/genetics Polymorphism, Genetic/genetics Promoter Regions, Genetic/genetics Risk Factors Tumor Necrosis Factor-alpha/genetics Whites/genetics
Chemicals
HLA-DR Antigens Tumor Necrosis Factor-alpha
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Rudwaleit M
Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, UK.
Tikly M
Khamashta M
Gibson K
Klinke J
Hughes G
Wordsworth P
Article Info
Journal
The Journal of rheumatology
Abbr.
J Rheumatol
ISSN
0315-162X
Published
1996-10-00
Pages
1725-8
Language
English
Region
Canada
NLM ID
7501984
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com